2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide

C51H67BBr2N12O8 — CID 161115565

IUPAC2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
SMILESCC1(C)OB(c2cnc3c(c2)CCCN3C(N)=O)OC1(C)C.CN(C)C(=O)Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1.CN(C)C(=O)Cc1cncc(Br)c1.CNC.O=C(O)Cc1cncc(Br)c1
InChIInChI=1S/C18H21N5O2.C15H22BN3O3.C9H11BrN2O.C7H6BrNO2.C2H7N/c1-22(2)16(24)7-12-6-14(10-20-9-12)15-8-13-4-3-5-23(18(19)25)17(13)21-11-15;1-14(2)15(3,4)22-16(21-14)11-8-10-6-5-7-19(13(17)20)12(10)18-9-11;1-12(2)9(13)4-7-3-8(10)6-11-5-7;8-6-1-5(2-7(10)11)3-9-4-6;1-3-2/h6,8-11H,3-5,7H2,1-2H3,(H2,19,25);8-9H,5-7H2,1-4H3,(H2,17,20);3,5-6H,4H2,1-2H3;1,3-4H,2H2,(H,10,11);3H,1-2H3
InChIKeyUKGRRCHARMUFLA-UHFFFAOYSA-N
MW1146.79 g/mol
LogP5.60
Rot. Bonds8

About 2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide

2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide (PubChem CID 161115565) has the molecular formula C51H67BBr2N12O8 and a molecular weight of 1146.79 g/mol. Its IUPAC name is 2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide.

Molecular Properties

Compound Name2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
PubChem CID161115565
Molecular FormulaC51H67BBr2N12O8
Molecular Weight1146.79 g/mol
Exact Mass1144.37
IUPAC Name2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide
SMILESCC1(C)OB(c2cnc3c(c2)CCCN3C(N)=O)OC1(C)C.CN(C)C(=O)Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1.CN(C)C(=O)Cc1cncc(Br)c1.CNC.O=C(O)Cc1cncc(Br)c1
InChIInChI=1S/C18H21N5O2.C15H22BN3O3.C9H11BrN2O.C7H6BrNO2.C2H7N/c1-22(2)16(24)7-12-6-14(10-20-9-12)15-8-13-4-3-5-23(18(19)25)17(13)21-11-15;1-14(2)15(3,4)22-16(21-14)11-8-10-6-5-7-19(13(17)20)12(10)18-9-11;1-12(2)9(13)4-7-3-8(10)6-11-5-7;8-6-1-5(2-7(10)11)3-9-4-6;1-3-2/h6,8-11H,3-5,7H2,1-2H3,(H2,19,25);8-9H,5-7H2,1-4H3,(H2,17,20);3,5-6H,4H2,1-2H3;1,3-4H,2H2,(H,10,11);3H,1-2H3
InChIKeyUKGRRCHARMUFLA-UHFFFAOYSA-N
XLogP5.60
TPSA265.52 Ų
H-Bond Donors4
H-Bond Acceptors13
Rotatable Bonds8
Heavy Atoms74
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001146.79
LogP ≤ 55.60
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide?
The IUPAC name of 2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide (CID 161115565) is 2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide.
What is the SMILES notation for 2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide?
The canonical SMILES for 2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide is CC1(C)OB(c2cnc3c(c2)CCCN3C(N)=O)OC1(C)C.CN(C)C(=O)Cc1cncc(-c2cnc3c(c2)CCCN3C(N)=O)c1.CN(C)C(=O)Cc1cncc(Br)c1.CNC.O=C(O)Cc1cncc(Br)c1.
What is the InChIKey of 2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide?
The InChIKey is UKGRRCHARMUFLA-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H21N5O2.C15H22BN3O3.C9H11BrN2O.C7H6BrNO2.C2H7N/c1-22(2)16(24)7-12-6-14(10-20-9-12)15-8-13-4-3-5-23(18(19)25)17(13)21-11-15;1-14(2)15(3,4)22-16(21-14)11-8-10-6-5-7-19(13(17)20)12(10)18-9-11;1-12(2)9(13)4-7-3-8(10)6-11-5-7;8-6-1-5(2-7(10)11)3-9-4-6;1-3-2/h6,8-11H,3-5,7H2,1-2H3,(H2,19,25);8-9H,5-7H2,1-4H3,(H2,17,20);3,5-6H,4H2,1-2H3;1,3-4H,2H2,(H,10,11);3H,1-2H3.
What are the key properties of 2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide?
2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide has a molecular weight of 1146.79 g/mol, XLogP of 5.60, 8 rotatable bonds, 4 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(5-bromo-3-pyridinyl)acetic acid;2-(5-bromo-3-pyridinyl)-N,N-dimethylacetamide;6-[5-[2-(dimethylamino)-2-oxoethyl]-3-pyridinyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide;N-methylmethanamine;6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide is sourced from PubChem (CID 161115565), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).